Sato K, Hosaka K, Ohi S, Uchiyama H, Tokieda Y, Ishiwata I
Department of Applied Biological Science, Nihon University College of Bioresource Sciences.
Hum Cell. 2000 Dec;13(4):197-202.
At present, two methods for cloning mammals by nuclear transfer are employed. The first is based on cell fusion and has been applied to domestic animals, such as sheep, cows, and goats. While, nuclear microinjection has been used in mice only. Cloning by nuclear transfer has been reported mainly with cells from primary culture and freshly isolated cells. Here, using ES cell line TT2, we tried to produce clone mouse embryos by the two methods. With ES cell line TT2 (10-13 passaged), 16% of reconstructed oocytes microinjected with the nuclei developed in vitro to the morula/blastocycst stage, and 50% of these embryos developed to fetuses until 14 dpc when transferred to pseudopregnant females. At 20 dpc implanted sites were degenerated and absorbed. Also, in vitro development of embryos reconstructed by electrofusion shown similar results. But, when transferred to recipients, subsequent development of embryos showed lower rates, as compared with embryos microinjected and from recipients live-born pups could not be obtained.
目前,采用了两种通过核移植克隆哺乳动物的方法。第一种基于细胞融合,已应用于家畜,如绵羊、奶牛和山羊。而核显微注射仅用于小鼠。核移植克隆主要报道使用原代培养细胞和新鲜分离的细胞。在此,我们使用ES细胞系TT2,尝试通过这两种方法生产克隆小鼠胚胎。对于ES细胞系TT2(传代10 - 13次),16%注射了细胞核的重构卵母细胞在体外发育到桑椹胚/囊胚阶段,当将这些胚胎移植到假孕母鼠体内时,50%的胚胎发育到14天胚龄的胎儿阶段。在20天胚龄时,着床部位退化并被吸收。此外,通过电融合重构的胚胎在体外发育也显示出类似结果。但是,当将这些胚胎移植到受体时,与显微注射的胚胎相比,后续胚胎发育率较低,并且无法从受体获得存活出生的幼崽。